Ablation is a minimal invasive medical procedure to destroy the abnormal tissues. It is performed with the help of probes that can be inserted through the skin or by using catheters that can be inserted through an artery or energy beams to reach the area that needs to be treated. An imaging technique such as MRI or rotational angiography is used to guide the probes or catheters to the site during ablation.

The world ablation device market is estimated to grow from $3,047 million in 2015 to $6,658 million by 2022 at a CAGR of 11.7% from 2016 to 2022. This can be attributed to the increase in demand for minimal invasive surgeries and increase in the prevalence of patients with chronic illnesses. Other factors such as minimal damage and blood loss, and short duration are some of the factors that contribute towards the growth of this market. However, stringent government regulations and unstable reimbursement policies restrain the market growth.

By technology, the ablation devices market is broadly categorized into thermal and non-thermal technologies. Thermal technologies comprise microwave, electrical, light, radiation, ultrasound, radiofrequency, and hydrothermal technologies, and each of these are further subcategorized. Thus, electrical ablation includes electrical ablators and electronic brachytherapy, while light ablation includes cold and exicmer laser. In addition, radiation ablation is sub-categorized into brachytherapy, stereotactic radiotherapy & radiosurgery, stereotactic body radiation, image guided radiation therapy, intensity modulated radiation therapy, and proton beam therapy. While ultrasound ablation is sub-divided into high intensity focused ultrasound (HIFU), magnetic resonance imaging-guided focused ultrasound (MRI-FUS), ultrasonic surgical systems, and shock wave lithotripsy; radiofrequency ablation is sub-divided into temperature controlled, fluid cooled, and catheter manipulation systems. However, the non-thermal technology market comprises cryoablation and hydromechanical ablation, wherein Cryoablation includes tissue contact probe, cryogen spray probe, and epidermal & subcutaneous cryoablation devices.

By applications, the ablation devices market is segmented into cancer, cardiology, ophthalmology, gynecology, urology, orthopedics, and other medical conditions. On the basis of function, the market is divided into automated/robotic and conventional ablation devices. Based on procedure, the market is segmented as aesthetics-skin rejuvenation & tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser- and other energy-based therapies/ holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression & denervation, varicose veins, atrial fibrillation, tumor ablation, and others. By geography, the ablation devices market is categorized into North America, Europe, Asia-Pacific, and LAMEA.

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players. For instance, on 26th January 2016, Medtronic PLC acquired Covidien to expand their access and improve their clinical outcomes at lower cost. Moreover, this acquisition has helped Medtronic PLC to compete with Johnson & Johnson. Boston Scientific Corporation acquired Cosman Medical on July 27, 2016to improve its neuromodulation portfolio and help provide innovative solutions for chronic pain treatment.

KEY MARKET BENEFITS:

Quantitative analysis of the current trends and market estimations from 2014 to 2022 is presented to identify potential market opportunities.
The report provides an in-depth analysis of the market and total revenue generated during the forecast period.
A detailed analysis based on applications and procedures are presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.


KEY MARKET SEGMENTS:

The world ablation devices market segmentation is explained below.

By Technology

Thermal Ablation
Electrical
Electrical Ablators
Argon Plasma/Beam Coagulator
Irreversible Electroporation
Electronic Brachytherapy
Radiation
Brachytherapy
High-Dose-Rate Brachytherapy
Pulsed-Dose-Rate Brachytherapy
Permanent Seed Brachytherapy
Stereotactic Radiotherapy & Radiosurgery
Stereotactic Body Radiation
Image Guided Radiation Therapy
Intensity Modulated Radiation Therapy
Proton Beam Therapy
Radiofrequency
Temperature Controlled
Fluid Cooled
Catheter Manipulation Systems
Light
Cold Lasers
Excimer Lasers
Ultrasound
High Intensity Focused Ultrasound (HIFU)
Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
Ultrasonic Surgical Systems
Shock Wave Lithotripsy
Microwave
Hydrothermal
Non-Thermal Ablation
Cryoablation
Tissue Contact Probe
Cryogen Spray Probe
Epidermal and Subcutaneous Cryoablation Devices
Hydromechanical Ablation

By Application

Cancer
Cardiovascular
Ophthalmology
Gynecology
Urology
Orthopedics
Others

By Function

Automated/Robotic
Conventional

By Procedure

Aesthetics-Skin Rejuvenation and Tightening
Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
Benign Prostatic Hyperplasia
Transurethral Needle Ablation
Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
Stress Urinary Incontinence
Menorrhagia/Endometrial Ablation
Uterine Fibroids
Spinal Decompression and Denervation
Varicose Veins
Atrial Fibrillation
Tumor Ablation
Others

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Rest of LAMEA

COMPANY PROFILES:

The key players profiled in this report are listed below:
St. Jude Medical, Inc.
Medtronic PLC
Boston Scientific Corporation
AngioDynamics, Inc.
AtriCure, Inc.
Conmed Corporation
Olympus Corporation
Smith & Nephew PLC
BTG plc
Johnson & Johnson

Other players in the RPM market include (profiles not included in the report)

Accuray Incorporated
C.R. Bard, Inc.
Varian Medical Systems, Inc.
Elekta AB
Misonix, Inc.
Hologic, Inc.
Stryker Corporation
EDAP TMS S.A.
Japan Lifeline Co., Ltd.
Halyard Health, Inc.
Merit Medical Systems, Inc.
Integra Lifesciences Holdings Corporation
Abbott Laboratories
Terumo Corporation